120 related articles for article (PubMed ID: 7083193)
21. Significance of aromatase activity in human breast cancer.
Miller WR; Hawkins RA; Forrest AP
Cancer Res; 1982 Aug; 42(8 Suppl):3365s-3368s. PubMed ID: 7083201
[TBL] [Abstract][Full Text] [Related]
22. Effect of aminoglutethimide on the structure and function of rat adrenals.
Chung KW
Res Commun Chem Pathol Pharmacol; 1982 Aug; 37(2):215-26. PubMed ID: 6291109
[TBL] [Abstract][Full Text] [Related]
23. Induction of cytochrome P450 2B1 in rat liver by the aromatase inhibitor aminoglutethimide.
Murray M; Cantrill E; Farrell GC
J Pharmacol Exp Ther; 1993 Apr; 265(1):477-81. PubMed ID: 8474030
[TBL] [Abstract][Full Text] [Related]
24. Plasma estrogen suppression with aromatase inhibitors evaluated by a novel, sensitive assay for estrone sulphate.
Lønning PE; Geisler J; Johannessen DC; Ekse D
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):255-60. PubMed ID: 9365198
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of imidazole based compounds as cytochrome P-450 inhibitors.
Ahmed S; Smith JH; Nicholls PJ; Whomsley R; Cariuk P
Drug Des Discov; 1995 Aug; 13(1):27-41. PubMed ID: 8882899
[TBL] [Abstract][Full Text] [Related]
26. A new hypothesis based on suicide substrate inhibitor studies for the mechanism of action of aromatase.
Covey DF; Hood WF
Cancer Res; 1982 Aug; 42(8 Suppl):3327s-3333s. PubMed ID: 7083195
[TBL] [Abstract][Full Text] [Related]
27. In vitro inhibition of aromatase by the enantiomers of aminoglutethimide and analogs.
Ogbunude PO; Aboul-Enein HY
Chirality; 1994; 6(8):623-6. PubMed ID: 7857773
[TBL] [Abstract][Full Text] [Related]
28. Adequacy of estrogen suppression with aminoglutethimide and hydrocortisone as treatment of human breast cancer: correlation of hormonal data with clinical responses.
Santen RJ; Worgul TJ; Samojlik E; Boucher AE; Lipton A; Harvey H
Cancer Res; 1982 Aug; 42(8 Suppl):3397s-3401s. PubMed ID: 7083205
[TBL] [Abstract][Full Text] [Related]
29. Biochemistry and pharmacology of 7alpha-substituted androstenediones as aromatase inhibitors.
Brueggemeier RW; O'Reilly JM; Lovely CJ; Ward PJ; Quinn AL; Baker D; Darby MV; Gu XJ; Gilbert NE
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):247-54. PubMed ID: 9365197
[TBL] [Abstract][Full Text] [Related]
30. Introduction to the conference, Aromatase: New Perspectives for Breast Cancer.
Santen RJ
Cancer Res; 1982 Aug; 42(8 Suppl):3268s. PubMed ID: 7083183
[No Abstract] [Full Text] [Related]
31. [Aromatase inhibitors--new possibilities in treatment of breast carcinoma].
Friedrichs K; Jänicke F
Praxis (Bern 1994); 1998 Apr; 87(17):584-8. PubMed ID: 9623325
[TBL] [Abstract][Full Text] [Related]
32. [Features of breast ultrasound image and its correlation with estradiol and progesterone level in different phases of menstrual cycle in normal women].
Zhou YZ; Jiang YX; Sun Q; Zhang SQ; Zhang Y; Chen FL; Lin SQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):609-13. PubMed ID: 12901108
[TBL] [Abstract][Full Text] [Related]
33. The role of aromatase inhibitors in breast cancer.
Powles TJ
Semin Oncol; 1983 Dec; 10(4 Suppl 4):20-4. PubMed ID: 6367051
[TBL] [Abstract][Full Text] [Related]
34. Aromatase inhibition by an 11,13-dihydroderivative of a sesquiterpene lactone.
Blanco JG; Gil RR; Bocco JL; Meragelman TL; Genti-Raimondi S; Flury A
J Pharmacol Exp Ther; 2001 Jun; 297(3):1099-105. PubMed ID: 11356934
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of human placental progesterone and estrogen synthesis in early human gestation by aminoglutethimide in vivo.
Rabe T; Mösch R; Franke C; Nobakht N; Runnebaum B
J Steroid Biochem; 1983 Mar; 18(3):291-6. PubMed ID: 6827834
[TBL] [Abstract][Full Text] [Related]
36. Additive effects of aminoglutethimide, testololactone, and 4-hydroxyandrostenedione as inhibitors of aromatase.
Santner SJ; Rosen H; Osawa Y; Santen RJ
J Steroid Biochem; 1984 Jun; 20(6A):1239-42. PubMed ID: 6748639
[TBL] [Abstract][Full Text] [Related]
37. Clinical use of aromatase inhibitors in the treatment of advanced breast cancer.
Trunet PF; Vreeland F; Royce C; Chaudri HA; Cooper J; Bhatnagar AS
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):241-5. PubMed ID: 9365196
[TBL] [Abstract][Full Text] [Related]
38. Endocrine effects of low dose aminoglutethimide as an aromatase inhibitor in the treatment of breast cancer.
Stuart-Harris R; Dowsett M; D'Souza A; Donaldson A; Harris AL; Jeffcoate SL; Smith IE
Clin Endocrinol (Oxf); 1985 Feb; 22(2):219-26. PubMed ID: 2985301
[TBL] [Abstract][Full Text] [Related]
39. Aromatase inhibitors--mechanisms for non-steroidal inhibitors.
Vanden Bossche HV; Moereels H; Koymans LM
Breast Cancer Res Treat; 1994; 30(1):43-55. PubMed ID: 7949204
[TBL] [Abstract][Full Text] [Related]
40. Aromatase inhibitors in breast cancer therapy.
Brueggemeier RW
Expert Rev Anticancer Ther; 2002 Apr; 2(2):181-91. PubMed ID: 12113240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
